Scholarlink

Objective <p>This study aimed to evaluate the therapeutic effects of ghrelin, a 28-amino acid peptide hormone with immunomodulatory, anti-inflammatory, antifibrotic, and antioxidant properties, on intrauterine adhesions (IUA) in a rat model.</p> Methods <p>Twenty-eight adult female rats were divided into four groups: control, IUA model, low-dose ghrelin (20&#xa0;ng/kg), and high-dose ghrelin (40&#xa0;ng/kg). IUA was induced using 0.2&#xa0;ml of trichloroacetic acid (TCA) injected into the right uterine horn. After three estrous cycles, rats received ghrelin injections under radiological guidance into the uterine cavity for seven days. Uterine tissues were collected for histological examination and immunohistochemical analysis targeting markers such as vascular endothelial growth factor (VEGF), type 1 collagen, tumor necrosis factor-alpha (TNFα), fibroblast growth factor 2 (FGF2), and hypoxia-inducible factor 1-alpha (HIF-1α).</p> Results <p>Ghrelin administration resulted in significant weight gain starting from day 5 (p &lt; 0.001). The IUA group exhibited the lowest uterine wall thickness, which improved dose-dependently with ghrelin treatment (p &lt; 0.001). Histopathological findings in the IUA group included epithelial degeneration, lumen narrowing, inflammation, fibrosis, and glandular atrophy, all of which were reversed with ghrelin. Immunohistochemical analysis showed the highest expression of type 1 collagen, TNFα, HIF-1α, and FGF2 in the IUA group, which decreased dose-dependently with ghrelin (p &lt; 0.001). Conversely, VEGF expression, which was lowest in the IUA group, increased significantly with ghrelin administration in a dose-dependent manner.</p> Conclusions <p>Ghrelin demonstrated favorable therapeutic effects in reversing histological and molecular alterations associated with intrauterine adhesions. These findings suggest that ghrelin may represent a promising candidate for IUA treatment, warranting further experimental and clinical investigation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The Impact of Ghrelin on Intrauterine Adhesions: Insights from Experimental Models

  • 期刊论文

  • 发表日期：

    2025年8月21日

查看全文
  • Ebru Eroğlu,
  • Canberk Tomruk,
  • Cansın Şirin Tomruk,
  • Ismet Hortu,
  • Timur Kose,
  • Yiğit Uyanikgil

摘要

Objective

This study aimed to evaluate the therapeutic effects of ghrelin, a 28-amino acid peptide hormone with immunomodulatory, anti-inflammatory, antifibrotic, and antioxidant properties, on intrauterine adhesions (IUA) in a rat model.

Methods

Twenty-eight adult female rats were divided into four groups: control, IUA model, low-dose ghrelin (20 ng/kg), and high-dose ghrelin (40 ng/kg). IUA was induced using 0.2 ml of trichloroacetic acid (TCA) injected into the right uterine horn. After three estrous cycles, rats received ghrelin injections under radiological guidance into the uterine cavity for seven days. Uterine tissues were collected for histological examination and immunohistochemical analysis targeting markers such as vascular endothelial growth factor (VEGF), type 1 collagen, tumor necrosis factor-alpha (TNFα), fibroblast growth factor 2 (FGF2), and hypoxia-inducible factor 1-alpha (HIF-1α).

Results

Ghrelin administration resulted in significant weight gain starting from day 5 (p < 0.001). The IUA group exhibited the lowest uterine wall thickness, which improved dose-dependently with ghrelin treatment (p < 0.001). Histopathological findings in the IUA group included epithelial degeneration, lumen narrowing, inflammation, fibrosis, and glandular atrophy, all of which were reversed with ghrelin. Immunohistochemical analysis showed the highest expression of type 1 collagen, TNFα, HIF-1α, and FGF2 in the IUA group, which decreased dose-dependently with ghrelin (p < 0.001). Conversely, VEGF expression, which was lowest in the IUA group, increased significantly with ghrelin administration in a dose-dependent manner.

Conclusions

Ghrelin demonstrated favorable therapeutic effects in reversing histological and molecular alterations associated with intrauterine adhesions. These findings suggest that ghrelin may represent a promising candidate for IUA treatment, warranting further experimental and clinical investigation.